Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1992 Oct;49(10):732–735. doi: 10.1136/oem.49.10.732

Survival of asbestos insulation workers with mesothelioma.

J Ribak 1, I J Selikoff 1
PMCID: PMC1012150  PMID: 1419863

Abstract

Malignant mesothelioma is a lethal disease. It is rare in the general population; however, workers exposed to asbestos suffer significant burdens of the neoplasm. The survival time of 457 consecutive fatal cases of pleural and peritoneal mesothelioma that occurred among 17,800 asbestos insulation workers observed prospectively from 1 January 1967 to 1 January 1987 was studied. Mean survival time from initial presentation of the disease to death was 11.4 months for the pleural mesothelioma patients compared with 7.4 months for the peritoneal group. This difference was statistically significant. Mean survival time from diagnosis to death was shorter for both groups of patients: 8.4 months for pleural mesothelioma v 5.8 months for the peritoneal cases. In conclusion, survival time in mesothelioma patients is short; most die within a year from the onset of the initial symptoms. No effective therapy is yet available.

Full text

PDF
732

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams V. I., Unni K. K., Muhm J. R., Jett J. R., Ilstrup D. M., Bernatz P. E. Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer. 1986 Oct 1;58(7):1540–1551. doi: 10.1002/1097-0142(19861001)58:7<1540::aid-cncr2820580727>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  2. Antman K. H. Current concepts: malignant mesothelioma. N Engl J Med. 1980 Jul 24;303(4):200–202. doi: 10.1056/NEJM198007243030407. [DOI] [PubMed] [Google Scholar]
  3. Blake P. R., Catterall M., Emerson P. A. Pleural mesothelioma treated by fast neutron therapy. Thorax. 1985 Jan;40(1):72–73. doi: 10.1136/thx.40.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brenner J., Sordillo P. P., Magill G. B. An unusual presentation of malignant mesothelioma: the incidental finding of tumor in the hernia sac during herniorrhaphy. J Surg Oncol. 1981;18(2):159–161. doi: 10.1002/jso.2930180209. [DOI] [PubMed] [Google Scholar]
  5. Brenner J., Sordillo P. P., Magill G. B. Seventeen year survival in a patient with malignant peritoneal mesothelioma. Clin Oncol. 1981 Sep;7(3):249–251. [PubMed] [Google Scholar]
  6. Chahinian A. P., Pajak T. F., Holland J. F., Norton L., Ambinder R. M., Mandel E. M. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med. 1982 Jun;96(6 Pt 1):746–755. doi: 10.7326/0003-4819-96-6-746. [DOI] [PubMed] [Google Scholar]
  7. DeWys W. D., Malone W. F., Butrum R. R., Sestili M. A. Clinical trials in cancer prevention. Cancer. 1986 Oct 15;58(8 Suppl):1954–1962. doi: 10.1002/1097-0142(19861015)58:8+<1954::aid-cncr2820581425>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  8. Dorward A. J., Stack B. H. Diffuse malignant pleural mesothelioma in Glasgow. Br J Dis Chest. 1981 Oct;75(4):397–402. doi: 10.1016/0007-0971(81)90027-9. [DOI] [PubMed] [Google Scholar]
  9. Gross J. L., Behrens D. L., Mullins D. E., Kornblith P. L., Dexter D. L. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res. 1988 Jan 15;48(2):291–296. [PubMed] [Google Scholar]
  10. Mårtensson G., Hagmar B., Zettergren L. Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study. Eur J Respir Dis. 1984 Apr;65(3):169–178. [PubMed] [Google Scholar]
  11. Nurminen M. The epidermiologic relationship between pleural mesothelioma and asbestos exposure. Scand J Work Environ Health. 1975 Jun;1(2):128–137. doi: 10.5271/sjweh.2854. [DOI] [PubMed] [Google Scholar]
  12. Ribak J., Lilis R., Suzuki Y., Penner L., Selikoff I. J. Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med. 1988 Mar;45(3):182–187. doi: 10.1136/oem.45.3.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SELIKOFF I. J., CHURG J., HAMMOND E. C. ASBESTOS EXPOSURE AND NEOPLASIA. JAMA. 1964 Apr 6;188:22–26. doi: 10.1001/jama.1964.03060270028006. [DOI] [PubMed] [Google Scholar]
  14. Selikoff I. J., Hammond E. C., Seidman H. Mortality experience of insulation workers in the United States and Canada, 1943--1976. Ann N Y Acad Sci. 1979;330:91–116. doi: 10.1111/j.1749-6632.1979.tb18711.x. [DOI] [PubMed] [Google Scholar]
  15. Suzuki Y. Pathology of human malignant mesothelioma. Semin Oncol. 1981 Sep;8(3):268–282. [PubMed] [Google Scholar]
  16. Vogelzang N. J., Schultz S. M., Iannucci A. M., Kennedy B. J. Malignant mesothelioma. The University of Minnesota experience. Cancer. 1984 Feb 1;53(3):377–383. doi: 10.1002/1097-0142(19840201)53:3<377::aid-cncr2820530302>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  17. WAGNER J. C., SLEGGS C. A., MARCHAND P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960 Oct;17:260–271. doi: 10.1136/oem.17.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wyon D. P. Use of thermal manikins in environmental ergonomics. Scand J Work Environ Health. 1989;15 (Suppl 1):84–94. [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES